Date

Wednesday, July 22, 2020

Venue

Sheraton Grand Jakarta Gandaria City Hotel
Sultan Iskandar Muda street, Jakarta 12240

Time

10:00 (GMT+7)

Agenda

AGM

1. Approval and ratification of the Company Annual Report of the financial year 2019, and approval and ratification of the Company's Financial Statements, including the Balance Sheet and Income statement of the financial year 2019, audited by an Independent Public Accountant Firm Aryanto, Amir Jusuf, Mawar & Partners, and approval of the Board of Commissioners oversight report of the financial year 2019, and to release and discharge of all responsibilities (volledig acquit et de charge) to all Board members for the management and supervision carried out in the financial year 2019.
2. Approval of the determination on the use of the Company net profit of the financial year 2019.
3. Election of an Independent Public Accountant Firm to audit the Company Financial Report of the financial year 2020, and authorise the Board of Directors of the Company to determine the honorarium of the Independent public accountant and other requirements.
4. Determination of income for Directors and Board of Commissioners of the Company in 2020, and the bonus of the Directors and Board of Commissioners in the performance of the financial year 2019.
5. Approval of amendments and restatement of the Company Articles of Association related to the Company's Articles of Association to be adjusted with Financial Services Authority Regulation No. 15/POJK.04/2020 regarding Plan and Organise Shareholders General Meeting of a Public Company.
6. Approval of the appointment of all Board members  

EGMS

1. Approval of the plan of the Company or its subsidiaries to issue bonds denominated in Rupiah and/or US Dollars (USD), in which the bond principal value to be issued for more of 50% (fifty per cent) of the Company equity and can be guaranteed with (i) corporate guarantee from the Company and/or its subsidiaries; and / or (ii) most or all of the Company assets and/or its subsidiaries' (if needed).
2. Approval of the Company plan related the business recovery of the Company and/or its subsidiaries affected from the Covid-19 pandemic, including to restructure the Company obligations and/or its subsidiaries, which will be carried out with the provisions of laws and regulations applied, ratification of the steps taken by the Directors and/or Board of Commissioners of the Company, either together or individually, and approval to authorise Directors and/or Board of Commissioners to carry out the Company's plan.